Filing Details

Accession Number:
0001209191-22-031958
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-25 18:07:13
Reporting Period:
2022-05-23
Accepted Time:
2022-05-25 18:07:13
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1706431 Vir Biotechnology Inc. VIR () 4
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1197020 L Vicki Sato C/O Vir Biotechnology, Inc.
499 Illinois Street, Suite 500
San Francisco CA 94158
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2022-05-23 6,405 $0.00 1,509,868 No 4 A Direct
Common Stock Disposition 2022-05-24 3,374 $23.82 1,506,494 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (Right to Buy) Acquisiton 2022-05-23 12,810 $0.00 12,810 $24.14
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,810 2023-05-23 2032-05-22 No 4 A Direct
Footnotes
  1. The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 28, 2022.